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Cystatin C (7-trace) is a basic protein with a molecular weight of 13,000-
14,500, which is present as a constituent of normal plasma, cerebrospinal fluid,
urine, and seminal fluid (1). Recently, a variant ofcystatin C was found to be the
major constituent of the amyloid fibrils in vessel walls of brains of patients with
the Icelandic form of hereditary cerebral hemorrhage with amyloidosis
(HCHWA-1) (2). At the time these latter observations were made, independent
studies were conducted on the regulation of lysozyme (LZM) secretion of mono-
nuclear phagocytes (3). Since LZM is also a constitutively secreted 14,500 mol
wt cationic protein, and since it had been suggested by others (4) that macro-
phages (M¢) may beamong many other cellscontaining cystatin C, the possibility
that cystatin C secreted into the culture medium by Mo could comigrate with
LZM on SDS-PAGE of MO supernatants was entertained. The question was of
particular interest to us in the context ofour studies on the downregulation of
selected Mo functions during chronic inflammatory states (3, 5, 6). Since cysteine
proteinases are released during inflammation, it seemed conceivable that cystatin
C, an inhibitor of cysteine proteinases, may be modulated during the inflamma-
tory response. In this article, data are presented showingthat, indeed, cystatin C
is secreted by monocytes/Mo and that its secretion is downregulated when the
cells are stimulated.
Materials and Methods
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Reagents.
￿
IFN was rat IFN-y (AMGen Biologicals, Thousand Oaks, CA). Descriptions
ofother reagents and additional procedures are given in references (3, 7).
Peritoneal Mo.
￿
Resident (Res)- and thioglycollate (TG)-elicited peritoneal MO were
obtained from C57BL/6J mice, and cultured as described (3). After incubation at 37°C
in an atmosphere of 10% C02, the cells were washed with warm HBSS and then cultured
either with medium only, DME, plus 0.2% lactoalbumin hydrolysate (LAH), with LPS or
IFN-y for 24 h at 37°C. After the incubation period, the conditioned medium (CM) was
removed from the dishes and prepared for SDS-PAGE (3).
HumanMonocytesandLymphocytes.
￿
Mononuclearcellswereseparatedfrom heparinized
bloods ofhealthy donors by Ficoll/Hypaque gradient centrifugation (5). Aliquots ofthe
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interphase cells were plated on 35-mm plastic petri dishes (Falcon Labware, Oxnard, CA)
containing cover slips in concentrations of 10" cells/ml of RPMI supplemented with 10%
heat-inactivated autologous serum. The cells were incubated for a minimum of 5 h in a
5% CO2 atmosphere. For some experiments, the nonadherent cells were removed and
designated lymphocyte preparations.
Cell Lines,
￿
The following cell lines were used in these studies: Rob me, SK-CO-1, HT-
29, HM-54, U937, J774, P388D.1, and human fetal fibroblasts. Conditioned media were
prepared from cell lines by culturing 106 cells in 1-2 ml of DME containing 0.2% LAH
for 24 h in 35-mm tissue culture dishes maintained at 37°C in an atmosphere of 10%
C02. The CM were then processed as described earlier.
Brain Cells. Astroglial and microglial cells were isolated from newborn C57BL/6J
mice as described (8). The CM were prepared as described above.
GelElectrophoresis, Western Blots, andProteinDetermination.
￿
Details ofthese procedures
have been published (3). The primary antibody for the Western blotting was rabbit
antiserum to purified amyloid protein monomer of amyloid fibrils obtained from the
leptomeninges of patients with HCHWA-I (2), and the secondary antibody was goat
antibody to rabbit IgG peroxidase (E-Y Laboratories, Inc., San Mateo, CA).
Detection and Quantitation of Cystatin C Secretion.
￿
The relative amounts of cystatin C
secreted into the medium by the variously treated macrophages were quantitated by
scanning densitometry of the Western blots or by a radioactive procedure. After washing
off unbound anti-HCHWA-I from the Western blots, the blots were incubated with "5I-
protein A (New England Nuclear, Boston, MA), washed with buffer several times, and
then autoradiographs were prepared. The autoradiographs were used as templates to
locate and excise the bands in the Western blots corresponding to the cystatin C. The
removed bands were counted in a gamma counter (model 4000; Beckman Instruments,
Inc., Fullerton, CA). The data were normalized to counts per milligram ofcellularprotein.
Immunoprecipitation ofCystatin C From Macrophage-conditioned Medium.
￿
Human histio-
cytic lymphoma cells U937 were incubated with ["S]methionine in methionine-free RPMI
1640 for 24 h. The radiolabeled proteins in the CM were immunoprecipitated with anti-
HCHWA-I. The immunoprecipitates were treated with protein A-Sepharose, the com-
plexes were washed several times, prepared for SDS-PAGE, electroblotted onto nitrocel-
lulose paper, and then autoradiographs were prepared.
Fluorescent Microscopy.
￿
Details of these procedures have been published (8).
Results and Discuss
As evident from several reports, many cell ty
Among human peripheral blood cells, indirect immunofluorescence proved
monocytes to be strongly
negative, even when cultured for 3 d (Fig. 1).
by immunoblotting culture supernatants of Mrs
an antibody to HCHWA-I (Fig. 2). Faint higher molecular weight bands were
also seen, which were due to aggregation of cystatin C (2). The cystatin C
detected in Map CM was shown to be synthesized by these cells (Fig. 3). This was
demonstrated by radiolabeling U937 cells for 24 h with [s5S]methionine and
then immunoprecipitating the cystatin C from the CM with anti-HCHWA-I .
Autoradiographs prepared from electroblots ofthe immunoprecipitates revealed
a major band identical to that identified by Western blots of CM as cystatin C
(Fig. 3). Table I summarizes the results of the examination for cystatin C secretion
by other cells that were selected at random from our tissue culture collection .
Thus, the release of cystatin C is not unique to monocytes/macrophages, but is
a property shared by many cell types, as has been reported by others (4, 9).
However, the present study focused primarily on monocytes/Mo because of the
ytes were
tion was substantiated
r different sources with191 4
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FIGURE 1 .
￿
Immunofluorescence of human peripheral blood monocytes stained with anti-
HCHWA-I . (A) 18-h culture. Arrow indicates negative lymphocyte . (B) Monocytes cultured
for 1 wk. Nonadherent cells and platelets are no longer present .
FIGURE 2 .
￿
Secretion of cystatin C into CM as detected by means
ofa Western blot, using antibody toHCHWA-I . (1) Purified human
urinary cystatin C; (2) CM from untreated resident mouse perito-
neal macrophages. (3-5) CM from 106 histiocytic lymphoma cells
ofJ774, P388D.1, and U937 cell lines, respectively.
FIGURE 3 .
￿
Electroblot of conditioned me-
dium from U937 cells demonstrates Cysta-
tin C synthesis and secretion by these cells.
Lane 1 : Western blot of Cystatin C from the
CM of [ s6Slmethionine labeled cells reacted
with anti-HCHWA-I . Lane 2 : Autoradi-
ograph of anti-HCHWA-I immunoprecipi-
tates obtained from the same sample run in
parallel .
possible role cystatin C may play in inflammation . The ubiquitous distribution
and constitutive secretion of this protein is reminiscent of other proteinase
inhibitors secreted by Mo . For instance, although the a, proteinase-inhibitor, as
well as the a2-macroglobulin, are functionally important products of mono-
cytes/MO (10, 11), other cells secrete these inhibitors as well (12, 13) . Cystatin C
is a potent inhibitor of cathepsin B, an enzyme contained in lysosomes and
released during phagocytosis and inflammation (14, 15) . Therefore, it isjudicious
to assume that this inhibitor serves to limit the acute inflammatory reaction . In
line with this hypothesis, it seemed of interest to determine whether, or how, an
inflammatory stimulus would affect the constitutive secretion of this proteinase
inhibitor by Mo . Accordingly, resident mouse peritoneal MO were incubated for
24 h in the presence of either medium alone, medium containing LPS, orTABLE I
Detection ofCystatin C by Western Blotting of the CultureMedia
from Various Cells
* Mean t SD.
* Mean t SD.
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Cell type*
Adenocarcinoma, colon (HT 29)
Adenocarcinoma, colon (SK-CO-1)
Melanoma (Rob Me)
Melanoma (HM-54)
Fetal fibroblasts
Astroglial and microglial cells
Peripheral blood lymphocytes
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* All cell lines were of human origin with the exception of the brain cells, which
were from newborn mice.
TABLE II
Effect ofLPS on Cystatin C Secretion by
Resident Peritoneal Macrophages
LPS treatment
pg/ml
Decrease in
cystatin-C secretion*
TABLE III
Effect ofIFN-y on Cystatin C Secretion by
Resident Peritoneal Macrophages
IFN treatment
U
None
I
10
102
101
Decrease in
cystatin-C secretion*
Control
1 .3 t 12.3
18.3 t 0.7
23.2 f 2.3
44.9 t 5.2
Detection of
cystatin-C
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medium containing IFN-.y . The relative differences among cystatin C levels in
the CM from these cells are shown in Tables II and 111. All three types of M¢
secreted cystatin C. However, the amount of cystatin C secreted by the cells
stimulated with LPS or by cells stimulated with IFN-y was much less than the
amount elaborated by untreated cells. The degree of suppression in cystatin C
secretion was dose dependent upon the LPS or IFN-y concentrations. IFN-a and
-,B treatments have also been shown to decrease cystatin C secretion (16). It was
further found that untreated TG-elicited Mo secreted 59% less cystatin C than
untreated resident Mo and that LPS treatment of TG-elicited MO caused a
further reduction to 71 % . This observation suggests that MO stimulation in vivo
with agents like TG which have been demonstrated to stimulate Mo and enhance
None
0.001
Control
6.6 t 9.3
0.01 25.0 t 2.2
0.10 30.8 f 5.2
1 .0 46.8 t 4.3
10.0 48.8 t 13.8191 6
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properties (17), may concomitantly downregulate other functions, like
the secretion of cystatin C. The present data show that Mo stimulated with the
same agents that we reported to decrease the constitutive secretion of LZM (3),
ly TG, LPS, and IFN, also caused a downregulation of cystatin C produc-
tion. The significance of a reduced level of LZM secretion during the inflam-
response is difficult to assess at the present time. However, a reduction
of cystatin C production has more obvious pathophysiologic
implications. Cystatin C is a cysteine proteinase inhibitor able to neutralize acid
hydrolases (14, 15), and recently it has been shown to possess close homologies
with the kininogens (2, 18). A decreased level ofthe antiproteinase-al-ant
has been shown to be associated with several chronic disease states (19), a
lobulin may also be affected (20, 21}, Thus, it is reasonable to
dititill chronic inflammatory conon, parcuary one ctomi-
es, downregulation ofcystatin
attributable to persistence of unopposed proteolysis,
human monocytes a
cell lines U93
1985.
ondary amyloidosis. J. Exp.
Summary
tively secreted protein of isolated
se peritoneal macrophages, as well as the histiocytic
P388D. 1, and J774. This proteinase inhibitor is not
es/macrophages, but was also identified in the
conditioned media from several primary cells, including brain cells, and diverse
established cell lines. In vitro treatment of resident mouse peritonea] macro
phages, with either LPS or IFN-y caused a downregulation in cystatin C secretion.
Iso diminished by macrophages that had been
hate in vivo, and treatment of these cells with LPS led to
sted that, under some inflammatory conditi
C may contribute to tissue pathology.
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